Joint-Stock Company (S.A.)
Matrx Pharmaceuticals
Matrx Pharmaceuticals Spółka Akcyjna
Matrx Pharmaceuticals Spółka Akcyjna (KRS 0000319753, NIP 8971749035) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. Matrx Pharmaceuticals operates in: Activities of holding companies (PKD 64.20.Z). Industry: Finance and banking. The company has been listed in the National Court Register since December 15, 2008. Matrx Pharmaceuticals's operations are currently suspended.
The company is currently suspended
Suspended since August 28, 2025
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Other activities
Founded
December 15, 2008
17 years in operation
Legal form
Joint-Stock Company (S.A.)
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
64.20.Z
Activities of holding companies
Share capital
15.0 M PLN
Board
1 person
Sup. board: 5
Registry entries
37
latest: September 3, 2025
Risk signals
No KPI data - financial statements and valuation are unavailable for this company.
People holding roles at Matrx Pharmaceuticals according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
Rate business credibility - Matrx Pharmaceuticals.
No ratings
Joint-Stock Company (S.A.)
Matrx Pharmaceuticals Spółka Akcyjna
20 historical registry entries for Matrx Pharmaceuticals
Registered office change, Address change, Commercial proxy change, Board change, Financial statement filed, Approval of the financial statement, Articles of association amended, Change in Section 3 (business activity and filings)
WR.VI NS-REJ.KRS/34270/17/776
Board change, Commercial proxy change
WA.XIII NS-REJ.KRS/49249/18/787
Board change
WA.XIII NS-REJ.KRS/75376/18/385
Filing document
Change in Section 6 (liquidation, bankruptcy or dissolution)
WA.XIII NS-REJ.KRS/49261/25/213
Competing companies or those operating in the same market segment as Matrx Pharmaceuticals (in Warszawa, industry: Finance and banking).
WARSZAWA· Finance and banking
Revenue 2024: 1.0 M PLN
WARSZAWA· Finance and banking
Revenue 2025: 851.4 K PLN
WARSZAWA· Finance and banking
Revenue 2025: 576.0 K PLN
HORNÓWEK· Finance and banking
Revenue 2024: 1.0 K PLN
WARSZAWA· Finance and banking
Revenue 2021: 0 PLN
WARSZAWA· Finance and banking
Revenue 2024: 0 PLN
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
The beneficial owners of Matrx Pharmaceuticals are: TADEUSZ DYKIEL (PL), PAWEŁ JELENIEWSKI (PL), and DOMINIK DYMECKI (PL).
No - all of Matrx Pharmaceuticals's beneficial owners hold Polish citizenship.
Matrx Pharmaceuticals's board has 1 member.
Latest reporting year
2017
Available years
9
Filing entries
0